KRYS
Krystal Biotech Inc Earnings
$148.9
Earnings Summary
Revenue | $88.18Mn |
Net Profits | $35.73Mn |
Net Profit Margins | 40.52% |
PE Ratio | 33.59 |
Krystal Biotech Inc’s revenue jumped 94.88% since last year same period to $88.18Mn in the Q1 2025. On a quarterly growth basis, Krystal Biotech Inc has generated -3.24% fall in its revenue since last 3-months.
Krystal Biotech Inc’s net profit jumped 3734.01% since last year same period to $35.73Mn in the Q1 2025. On a quarterly growth basis, Krystal Biotech Inc has generated -21.43% fall in its net profits since last 3-months.
Krystal Biotech Inc’s net profit margin jumped 1867.38% since last year same period to 40.52% in the Q1 2025. On a quarterly growth basis, Krystal Biotech Inc has generated -18.8% fall in its net profit margins since last 3-months.
Krystal Biotech Inc’s price-to-earnings ratio after this Q1 2025 earnings stands at 33.59.
Earnings per share (EPS) Estimates
EPS Estimate Current Quarter | 1.3 |
EPS Estimate Current Year | 1.3 |
Krystal Biotech Inc’s earning per share (EPS) estimates for the current quarter stand at 1.3 - a 26.21% jump from last quarter’s estimates.
Krystal Biotech Inc’s earning per share (EPS) estimates for the current year stand at 1.3.
Key Ratios
Earning Per Share (EPS) | 0 |
Krystal Biotech Inc’s earning per share (EPS) fell -100% since last year same period to 0 in the Q2 2025. This indicates that the Krystal Biotech Inc has generated -100% annual rate of fall in its earning per share (EPS) in the last 4 quarters.
Earnings Calendar
| Earnings Date | Estimated EPS | Reported EPS | Surprise % |
|---|---|---|---|
2025-05-06 | 1.03 | 1.2 | 16.14% |
2025-08-11 | 1.3 | 0 | -100% |
